STELITANO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 426
EU - Europa 312
AS - Asia 196
AF - Africa 9
OC - Oceania 7
SA - Sud America 3
Totale 953
Nazione #
US - Stati Uniti d'America 421
IE - Irlanda 142
CN - Cina 132
IT - Italia 76
SG - Singapore 39
FI - Finlandia 21
DE - Germania 17
IN - India 14
GB - Regno Unito 12
RU - Federazione Russa 9
AT - Austria 8
EG - Egitto 8
AU - Australia 7
FR - Francia 6
ES - Italia 4
SE - Svezia 4
CA - Canada 3
TR - Turchia 3
UA - Ucraina 3
BD - Bangladesh 2
CL - Cile 2
MX - Messico 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BR - Brasile 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IM - Isola di Man 1
KR - Corea 1
LT - Lituania 1
NL - Olanda 1
NO - Norvegia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 953
Città #
Dublin 112
Chandler 71
Boardman 53
Ashburn 50
Shanghai 34
Singapore 33
Helsinki 21
Pavia 21
Ann Arbor 20
Beijing 18
Lawrence 15
Princeton 15
Medford 14
Nanjing 11
Shenyang 10
Menlo Park 9
New York 8
Vienna 8
Wilmington 8
Corteolona 7
Dearborn 7
Nanchang 7
Chicago 6
Cinisello Balsamo 6
Milan 6
Washington 6
Changsha 5
Fairfield 5
Cagliari 4
Coventry 4
Delhi 4
Jiaxing 4
San Genesio ed Uniti 4
Tianjin 4
Armidale 3
Florence 3
Hangzhou 3
Hebei 3
Hefei 3
Istanbul 3
London 3
Los Angeles 3
Melbourne 3
Norwalk 3
Norwich 3
Nürnberg 3
Ottawa 3
Palma 3
Seattle 3
Shenzhen 3
Bangkok 2
Cluj-Napoca 2
Columbia 2
Corsico 2
Dhaka 2
Falkenstein 2
Gatchina 2
Hyderabad 2
Ismailia 2
Kishangarh 2
Kunming 2
Ludhiana 2
Rimini 2
Rome 2
Santa Clara 2
St Petersburg 2
Tlalpan 2
Trnava 2
Valparaíso 2
Verolanuova 2
Atlanta 1
Brno 1
Brussels 1
Buffalo 1
Cambridge 1
Castletown 1
Central Coast 1
Changchun 1
Chongqing 1
Dallas 1
Dubai 1
Frankfurt am Main 1
Fuzhou 1
Gainesville 1
Gwanak-gu 1
Houston 1
Jacksonville 1
Jinan 1
Lodi 1
Monza 1
Mumbai 1
Munich 1
Naples 1
Ningbo 1
Orange 1
Piscataway 1
Porto Alegre 1
Quzhou 1
Redditch 1
Redwood City 1
Totale 728
Nome #
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents 75
Targeting iron uptake pathway for the development of novel antitubercular drugs. 60
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents 52
Exploring the role of the heterocyclic moiety of 5-(4-nitrophenyl)-2-furoic acid, a promising inhibitor of MbtI from Mycobacterium tuberculosis. 48
Characterization of mycobacterial enzymes as targets for potential antitubercular compounds. 48
Improve protection to prevent infections: application of reverse vaccinology against cystic fibrosis pathogens. 47
Multi-target antitubercular drugs: identification of novel dual MbtI and MptpB inhibitors. 45
Structural insights for the development of novel antituberculars targeting the iron uptake pathway. 39
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 39
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 38
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 37
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. 33
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 33
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 29
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 29
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 29
From virulence factors to drug development: MbtI as an effective Mycobacterium tuberculosis target 27
Synthesis, characterization, and biological evaluation of new derivatives targeting MbtI as antitubercular agents 27
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents 26
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 23
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 23
Synthesis and assessment of the in vitro and ex vivo activity of salicylate synthase (Mbti) inhibitors as new candidates for the treatment of mycobacterial infections 22
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 21
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand? 20
Mycobacterium abscessus siderophores biosynthesis as a target to inhibit the iron uptake mechanism 20
Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation 19
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research 19
Investigating the inhibition mechanism and catalytic cycle of MbtI, the salicylate synthase from Mycobacterium tuberculosis. 15
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis MbtI and MPtpB 15
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI. 13
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 11
Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity. 11
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors. 10
Phage therapy: an alternative approach to combating multi-drug-resistant bacterial infections in cystic fibrosis 8
Polymersomes as selective drug delivery carriers for innovative anti-TB agents. 8
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity 8
Structural and biochemical investigations into the binding mode of furan-based inhibitors of MbtI from M. tuberculosis. 4
Totale 1.031
Categoria #
all - tutte 6.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 0 1 10 2 1 15 2 2
2020/202125 1 1 0 0 2 2 3 11 2 0 1 2
2021/2022109 0 0 0 40 2 1 4 4 12 8 7 31
2022/2023283 18 29 11 10 14 20 0 21 141 1 15 3
2023/2024325 26 52 19 41 24 55 31 16 1 22 9 29
2024/2025174 37 55 20 12 31 19 0 0 0 0 0 0
Totale 1.031